2 Best ETFs to Buy Now to Build a Diversified Portfolio

NYSE: VTV | Vanguard Value ETF News, Ratings, and Charts

VTV – Despite a slight ease in inflation, the stronger-than-expected job report will likely encourage the Fed to continue tightening its policy. Amid this backdrop, fundamentally strong ETFs Vanguard Value Index Fund (VTV) and iShares iBoxx $ High Yield Corporate Bond ETF (HYG) could help investors diversify their portfolios. Read on….

October’s CPI data showed signs of inflation cooling down. Minutes from the Federal Reserve’s policy meeting released last month showed that the central bank intends to slow down the current pace of rate hikes.

However, the recent employment report indicated stronger-than-expected hiring momentum amid uncertain macroeconomic conditions. Despite mass layoffs, demand for workers continues to outpace the number of unemployed people looking for work. Such a robust labor market is expected to encourage the Fed to continue tightening its policy.

With recession fears looming, the market could remain under pressure in the near term. Therefore, investors could hedge their portfolios against the economic downturn by adding ETFs Vanguard Value Index Fund (VTV) and iShares iBoxx $ High Yield Corporate Bond ETF (HYG). These ETFs’ diverse holdings could help investors generate stable returns.

Vanguard Value Index Fund (VTV)

The Vanguard Group, Inc, manages VTV. It invests in value stocks of large-cap companies. It seeks to track the performance of the CRSP US Large Cap Value Index. The investment seeks to track the performance of the CRSP US Large Cap Value Index, which measures the investment return of large-cap value stocks.

As of December 02, VTV had $102.10 billion in assets under management (AUM) and a Net Asset Value (NAV) of $145.99. Its expense ratio of 0.04% is significantly lower than the category average of 0.48%.

The fund’s top holdings include UnitedHealth Group Inc (UNH) with a 3.08% weight, Berkshire Hathaway Inc. Class B (BRK.B) with a 3.04% weight, and Exxon Mobil Corporation (XOM) with a 2.74% weight. It has a total of 343 holdings.

The fund’s net inflows came in at $9.87 billion over the past year. VTV has gained 8.7% over the past three months and 4.1% over the past year to close the last trading session at $146.

VTV’s strong fundamentals are reflected in its POWR Ratings. The ETF has an overall rating of A, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

The ETF has an A grade for Trade, Buy & Hold, and Peer. Among the 86 ETFs in the A-rated Large Cap Value ETFs group, VTV is ranked first. Click here to see all POWR Ratings for VTV.

iShares iBoxx $ High Yield Corporate Bond ETF (HYG)

BlackRock Fund Advisors manages HYG. The fund invests in fixed-income markets of the globally developed region. It invests in U.S. dollar-denominated high-yield corporate bonds with a maturity of at least one year and less than 15 years and a sub-investment grade rating from Fitch, Moody’s, or S&P. The fund seeks to track the performance of the Markit iBoxx USD Liquid High Yield Index.

As of December 2, HYG had $18.83 billion in assets under management and a NAV of $75.10. Its expense ratio of 0.48% compares to the category average of 0.44%.

The fund’s top holdings include U.S. Dollar with a 1.72% weight, TransDigm, Inc. 6.25% 15-MAR-2026 with a 0.47% weight, and Mozart Debt Merger Sub, Inc. 3.875% 01-APR-2029 with a 0.42% weight. It has a total of 1,219 holdings.

Over the past three months, the fund’s net inflow came in at $5.93 billion. HYG has gained 3.6% over the past month to close its last trading session at $75.56.

HYG’s promising outlook is reflected in its POWR Ratings. The ETF has an overall B rating, equating to a Buy in our proprietary rating system.

It has an A grade for Trade and a B for Buy & Hold. It is ranked #18 out of 58 ETFs in the B-rated High Yield Bond ETFs group. To see the POWR Ratings of HYG for Peer, click here.


VTV shares were trading at $143.34 per share on Monday afternoon, down $2.66 (-1.82%). Year-to-date, VTV has declined -0.75%, versus a -15.05% rise in the benchmark S&P 500 index during the same period.


About the Author: Shweta Kumari


Shweta's profound interest in financial research and quantitative analysis led her to pursue a career as an investment analyst. She uses her knowledge to help retail investors make educated investment decisions. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
VTVGet RatingGet RatingGet Rating
HYGGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Should Investors BEWARE this Market?

The S&P 500 (SPY) has been on a tear since November 1st when the Fed started to make their dovish tilt opening the door to future rate cuts. Unfortunately they keep not happening and start date keeps getting pushed further and further out. That has many wondering if stocks are getting ahead of themselves setting things up for a fall. Thus a good time to tune into what investment veteran Steve Reitmeister has to say about the market outlook along with his trading plan and top picks to stay ahead of the pack. Read on below for more...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Is the Bull Market Growing Tired?

On the one hand it is fun to celebrate the new highs for the S&P 500 (SPY) that came in this Tuesday. On the other hand...it doesn’t make a lot of sense calling into question the next moves for the stock market. Read on below to appreciate investment veteran, Steve Reitmeister’s, market outlook and top picks to outperform.

Read More Stories

More Vanguard Value ETF (VTV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VTV News